Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.
about
CIViC databaseSuccessful control of heavily pretreated metastatic gastric cancer with the mTOR inhibitor everolimus (RAD001) in a patient with PIK3CA mutation and pS6 overexpressionPrognostic significance of phosphorylated 4E-binding protein 1 in non-small cell lung cancer.Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.The chemokine CXCL9 exacerbates chemotherapy-induced acute intestinal damage through inhibition of mucosal restitution.Anti-tumor effect of the mammalian target of rapamycin inhibitor everolimus in oral squamous cell carcinoma.4E-BP1 regulates the sensitivity of human glioma cells to chemotherapy through PI3K/Akt/mTOR-independent pathway.Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy of rapalogs for treating hepatocellular carcinoma.Combination treatment of RAD001 and BEZ235 exhibits synergistic antitumor activity via down-regulation of p-4E-BP1/Mcl-1 in small cell lung cancer.Phosphorylated 4E-binding protein 1 expression is associated with poor prognosis in small-cell lung cancer.
P2860
Q27612411-7A9F5923-78E9-49EB-AA36-0E5A14CEEAE7Q35606679-E70874E6-5963-4DA0-A4F6-051CF2F112DCQ35741086-6D0937CE-C6E4-4A99-AB07-951D950028AAQ36963020-5BA03FD4-C159-4AB8-AD43-2431577CB3DAQ38940305-F9D4D1D3-250B-43D2-89AF-9C75C164FB1DQ39038881-D3C75F73-B2AB-423C-AEC2-B291D3949C5FQ39041878-31F6DF65-2877-4E02-ABC6-461FFC12CB2BQ40859380-99A9B627-0004-46B9-9383-2B778DFF1212Q47184289-08F830B8-B4DF-4E6C-98C9-55028A79403FQ52911593-720EDF70-B984-4B3E-8B13-ADC818EB3ED1
P2860
Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.
@ast
Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.
@en
Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.
@nl
type
label
Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.
@ast
Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.
@en
Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.
@nl
prefLabel
Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.
@ast
Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.
@en
Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.
@nl
P2093
P3181
P1433
P1476
Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.
@en
P2093
Chie Tanaka
Daisuke Kobayashi
Goro Nakayama
Kenta Iwasaki
Masahiko Koike
Michitaka Fujiwara
Norifumi Ohashi
Takaaki Kobayashi
Tetsuo Nishi
Yasuhiro Kodera
P3181
P356
10.1016/J.CANLET.2013.01.004
P407
P577
2013-05-01T00:00:00Z